tiprankstipranks
BofA moves to No Rating on Enfusion after Clearwater Analytics deal
PremiumThe FlyBofA moves to No Rating on Enfusion after Clearwater Analytics deal
5d ago
Clearwater-Enfusion merger makes sense strategically, says Oppenheimer
Premium
The Fly
Clearwater-Enfusion merger makes sense strategically, says Oppenheimer
5d ago
Enfusion downgraded to Market Perform from Outperform at William Blair
Premium
The Fly
Enfusion downgraded to Market Perform from Outperform at William Blair
5d ago
Clearwater Analytics to acquire Enfusion for $11.25 per share in cash, stock
PremiumThe FlyClearwater Analytics to acquire Enfusion for $11.25 per share in cash, stock
5d ago
Enfusion price target raised to $11.50 from $10 at Piper Sandler
Premium
The Fly
Enfusion price target raised to $11.50 from $10 at Piper Sandler
26d ago
Enfusion price target raised to $13 from $11 at Stifel
Premium
The Fly
Enfusion price target raised to $13 from $11 at Stifel
1M ago
ENFN Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsENFN Upcoming Earnings Report: What to Expect?
3M ago
Enfusion jumps roughly 11% after report of sale exploration
Premium
The Fly
Enfusion jumps roughly 11% after report of sale exploration
4M ago
Enfusion exploring possible sale after receiving takeover interest, Reuters says
Premium
The Fly
Enfusion exploring possible sale after receiving takeover interest, Reuters says
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100